41 Clinical activity of BIND-014 (docetaxel nanoparticles for injectable suspension) as second-line therapy in patients (pts) with Stage III/IV non-small cell lung cancer
Authors:
- R. NataleRNR. Natale
- M. SocinskiMSM. Socinski
- L. HartLHL. Hart
- O. LipatovOLO. Lipatov
- D. SpigelDSD. Spigel
- B. GershenhornBGB. Gershenhorn
- G. WeissGWG. Weiss
- S. KazmiSKS. Kazmi
- N. KarasevaNKN. Karaseva
- O. GladkovOGO. Gladkov
- V. MoiseyenkoVMV. Moiseyenko
- J. SummaJSJ. Summa
- 1 November 2014
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 50, 19